Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: ITIL-306 in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of ITIL-306 in advanced solid tumors sponsored by Instil Bio has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
This completed NCI clinical trial reports on predictors of relapse in fallopian tube cancer, peritoneal cancer, and epithelial ovarian cance…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating STRO-002 in Chinese adults with epithelial ovarian cancer and other advanced malignant solid tumors ha…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
This update reports results from the Rucaparib Access Program (RAP) in Spain, summarizing clinical experience with rucaparib in patients wit…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Genomic BRCA and Extensive ovArian Cancer Testing
A completed clinical trial evaluated BRCA genomic testing and extensive ovarian cancer testing in epithelial ovarian cancer, primary periton…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER) [Phase 3]
Phase 3 trial evaluating cytoreductive surgery with HIPEC using mitomycin C for platinum-resistant recurrent epithelial ovarian cancer is cu…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
Real-world data assess the effectiveness and safety of niraparib in Korean women with primary and recurrent epithelial ovarian cancer. The s…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial of RC88 in platinum-resistant recurrent epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers [Phase 1]
Phase 1b study evaluating SL-172154 in combination with other agents in platinum-resistant ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian [Phase 1]
Phase I study evaluating autologous CAR T-cells targeting B7-H3 in recurrent epithelial ovarian cancer has results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update reports on the combination of MGC018 and MGD019 in participants with advanced solid tumors, including castration-r…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]
Phase 1, first-in-human dose-finding and expansion study of XmAb808 in combination with pembrolizumab in advanced solid tumors; the trial ha…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors [Phase 1, Phase 2]
A pharmacokinetic study evaluating the combination of lurbinectedin and irinotecan in selected solid tumors has completed (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: CART-meso in Mesothelin Expressing Cancers [Phase 1]
Phase 1 update on CART-meso, a mesothelin-targeted CAR T-cell therapy, tested in mesothelin-expressing cancers including metastatic pancreat…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy [Phase 3]
A Phase 3 trial update reports results for maintenance therapy with rucaparib and nivolumab in ovarian cancer patients who responded to fron…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating a biomarker-driven targeted therapy for recurrent platinum-resistant epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the safety of KAND567 in combination with carboplatin in w…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer [Phase 1]
A Phase 1 trial evaluating ribociclib in combination with PDR001 for metastatic hormone-receptor-positive (HR+) breast cancer, HER2-negative…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating pembrolizumab in patients with advanced solid tumors, including squamous cell carcinoma of the head and neck, tripl…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]
A Phase 2 trial (QUADRUPLE THREAT) evaluated RRx-001 in small cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and epith…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Efficacy of Letrozole in Recurrent Ovarian Cancer [Phase 3]
Phase 3 trial evaluating letrozole for recurrent epithelial ovarian cancer has been terminated; the update does not include efficacy results…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: PARPi and Ovarian Cancer Survival
A not-yet-recruiting clinical trial is investigating a PARP inhibitor for epithelial ovarian cancer and related cancers of the fallopian tub…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) [Phase 3]
A Phase 3 trial (LEPRE) is evaluating letrozole for estrogen/progesterone receptor-positive low-grade serous epithelial ovarian cancer and i…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [EARLY_Phase 1]
An early-phase study evaluating epacadostat given before surgery in newly diagnosed, advanced ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer [Phase 1, Phase 2]
PLX2853 was evaluated as a single agent and in combination with carboplatin in platinum-resistant epithelial ovarian cancer and other gyneco…